What problem does it solve?
Drug-discovery research often stalls on slow, repetitive gathering of basic molecule properties, target-linked bioactivity, and early interaction/safety signals from public biomedical databases.
Core Features & Use Cases
- Bioactive compound and target search (ChEMBL): Find targets and retrieve top bioactivity records to support hit/lead exploration and literature-style evidence gathering.
- Drug-likeness scoring (Lipinski Ro5 + Veber): Quickly assess oral-likeness using physicochemical proxies like MW, LogP, HBD/HBA, TPSA, and rotatable bonds.
- Safety and interaction signals (OpenFDA): Look up reported drug-drug interaction text and adverse event terms to inform risk-aware iteration.
- ADMET-style reasoning support with references: Provides an ADMET guide (CYP450 metabolism, hERG risk heuristics, and mitigation ideas) to structure interpretation and follow-up questions.
Quick Start
Use the drug-discovery skill to evaluate a candidate by first retrieving its ChEMBL identity/properties, then checking Ro5 and Veber drug-likeness, and finally summarizing OpenFDA interaction/adverse-event snippets relevant to the molecule name you provide.